Browsing: 2027

The DIII field always promises a fierce competition. Year after year, athletes continue to surprise audiences with new skills, superb performances, and historic moments, and 2027 will be no different. From powerhouse programs to dark horse individuals, let’s look ahead at a few who are likely to maintain momentum in the coming season

Aug 20 (Reuters) – U.S. employer healthcare costs are expected to rise 9.5% in 2027, pushing the average cost above $19,000 ‌per employee, driven by increased medical use and spending ‌on high-priced drugs, insurance broker Aon said on Thursday

Palvella TherapeuticsNASDAQ: PVLA is advancing topical therapies for serious rare skin diseases and vascular malformations that lack FDA-approved treatments, with its lead candidate, QTORIN rapamycin, moving toward a planned New Drug Application submission for microcystic lymphatic malformations

File- Muslim pilgrims circle the Kaaba and pray at the Grand mosque at the end of their Haj pilgrimage in the holy city of Mecca, Saudi Arabia August 13, 2019. Picture taken August 13, 2019. REUTERSUmit Bektas

Boise State University’s School of Public and Population Health, in collaboration with the Idaho Public Health Association, will co-host the Idaho Health Priorities Conference on March 1-3, 2027

For the complete transcript of the earnings call, please refer to the full earnings call transcript

‘Fox News Saturday Night’ host Jimmy Failla discusses the University of Michigan’s decision to drop letter grades for some 2027 freshmen on ‘America Reports.’

Footy Headlines can exclusively leak early images of the special AdidasReal Madrid 125th-anniversary lifestyle shirt. This retro-inspired piece will be released alongside the club’s official 125th-anniversary match kit in March 2027

Eli Lilly LLY announced positive top-line data from two late-stage studies evaluating its next-generation, experimental triple-acting incretin, retatrutide, in patients with obesity or those who are overweight as well as some of its most serious complications – type II diabetes and established cardiovascular disease

Eli LillyLLYfell 0.35% in premarket after reporting positive results from two further Phase 3 trials of retatrutide and confirming it will submit a biologics license application to the FDA in the first quarter of 2027. The drug targets three metabolic hormones, GLP-1, GIP and glucagon, against two for Lilly’s current Zepbound and one for Novo…